Global Enteromorpha Compressa Extract Market Strategic Research Report
By Type: Polysaccharide Content: <20%, Polysaccharide Content: 20%–50%, Polysaccharide Content: ≥50%–80%
By Application: Personal Care Products, Cosmetic, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: ICHIMARU PHARCOS(JP), Presperse(US), Provital(ES), Ephyla(FR), GREENTECH(FR), Vantage(US), BIO-EXTRACTS(LK), Akott(IT), NUWEN(FR), MediSea Biotech(FR), Odycea(FR), ELICITYL(FR), Algaia(FR), Seaweed Solutions AS(NO), Sinochem Nanjing(CN), Baoji Oasier Bio-Tech(CN), Amazy Organic(CN), Hunan MT Health(CN), Xi'an Seven Herb Biotech(CN), Qingdao Seawin Biotech(CN), Parchem(US), MakingCosmetics(US), BioSynth(CH), Alidans(ES), BioMolenez(FR)
Overview
Scope of the Report
The global Enteromorpha Compressa Extract market size is predicted to grow from US$ 353 million in 2025 to US$ 706 million in 2032; it is expected to grow at a CAGR of 10.5% from 2026 to 2032.
Ulva prolifera extract refers to a mixture of natural active ingredients obtained from marine green algae Ulva prolifera through processes such as water extraction, enzymatic hydrolysis, or supercritical fluid extraction. It is rich in polysaccharides (such as sulfated polysaccharides), amino acids, minerals, and polyphenols, and possesses moisturizing, antioxidant, soothing, and certain bioactive regulatory effects. It is widely used in functional skincare products, health foods, and marine biological resource development.
The Ulva prolifera extract industry chain mainly consists of upstream raw material acquisition (nearshore Ulva prolifera harvesting, cultivation, and preliminary drying), midstream extraction and processing (obtaining active ingredients such as sulfated polysaccharides through processes like water extraction, enzymatic hydrolysis, and membrane separation, followed by standardization), and downstream applications (functional skincare products, health foods, feed additives, and agricultural biostimulants, etc.). Upstream production is affected by seasonal outbreaks and resource distribution, resulting in lower added value and gross profit margins typically between 10% and 25%. Midstream extraction and processing, involving the enrichment and purification of active ingredients, possesses certain technological barriers, leading to gross profit margins generally between 30% and 60%. Downstream brands and formulations, leveraging functional claims and channel advantages, can achieve gross profit margins of 50% to 80%. Overall, the industry presents a typical marine biological extract industry structure of "resource-driven + technology-driven extraction value-added + terminal brand premium."
In 2025, the average price of Ulva prolifera extract was US$60 k/ton, with sales volume reaching 6,016 tons, and the total production capacity of Ulva prolifera extract in 2025 was 8,600 tons.
As an important branch of marine biological resource development, Ulva prolifera extract embodies a typical path of "high-value utilization of marine waste biological resources." Its core value lies in transforming seasonally occurring Ulva prolifera blooms along the coast (originally a burden on environmental governance) into functional raw materials rich in sulfated polysaccharides, amino acids, and minerals, showing potential applications in skincare, food, and agriculture. From an industry perspective, its advantages lie in the wide availability of raw materials, relatively low cost, and the "natural marine source" label, which helps align with the current trends of green sustainability and pure beauty. However, it also faces challenges such as insufficient stability of active ingredients, low standardization, and inadequate validation of high-end efficacy. Future development hinges on improving extraction and purification technologies, establishing a clear functional evaluation system, and extending into high-value-added applications (such as medical aesthetic raw materials and bioactive polysaccharides), thereby upgrading from a "resource-utilizing product" to a "functional high-end raw material."
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enteromorpha Compressa Extract market?
What factors are driving Enteromorpha Compressa Extract market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enteromorpha Compressa Extract market opportunities vary by end market size?
How does Enteromorpha Compressa Extract break out by Type, by Application?
This report presents a comprehensive overview of the global Enteromorpha Compressa Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Polysaccharide Content: <20%
- Polysaccharide Content: 20%–50%
- Polysaccharide Content: ≥50%–80%
Segment by Extraction Method
- Water Extraction
- Enzymatic Extraction
- Microwave-Assisted Extraction
Segment by Grade
- Agricultural Grade
- Food Grade
- Cosmetic Grade
Segment by Application
- Personal Care Products
- Cosmetic
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Enteromorpha Compressa Extract market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Personal Care Products, Cosmetic, Other evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Enteromorpha Compressa Extract Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Polysaccharide Content: <20%
- 3.1.3 Polysaccharide Content: 20%–50%
- 3.1.4 Polysaccharide Content: ≥50%–80%
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Personal Care Products
- 4.1.3 Cosmetic
- 4.1.4 Other
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 ICHIMARU PHARCOS(JP)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Presperse(US)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Provital(ES)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Ephyla(FR)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 GREENTECH(FR)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Vantage(US)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 BIO-EXTRACTS(LK)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Akott(IT)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 NUWEN(FR)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 MediSea Biotech(FR)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Odycea(FR)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 ELICITYL(FR)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Algaia(FR)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Seaweed Solutions AS(NO)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Sinochem Nanjing(CN)
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Baoji Oasier Bio-Tech(CN)
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Amazy Organic(CN)
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Hunan MT Health(CN)
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
- 8.19 Xi'an Seven Herb Biotech(CN)
- 8.19.1 Company Overview
- 8.19.2 Key Products & Segments
- 8.19.3 Financial Performance (2023–2025)
- 8.19.4 Business Strategy
- 8.19.5 SWOT Analysis
- 8.19.6 Strategic Implications (2026–2032)
- 8.20 Qingdao Seawin Biotech(CN)
- 8.20.1 Company Overview
- 8.20.2 Key Products & Segments
- 8.20.3 Financial Performance (2023–2025)
- 8.20.4 Business Strategy
- 8.20.5 SWOT Analysis
- 8.20.6 Strategic Implications (2026–2032)
- 8.21 Parchem(US)
- 8.21.1 Company Overview
- 8.21.2 Key Products & Segments
- 8.21.3 Financial Performance (2023–2025)
- 8.21.4 Business Strategy
- 8.21.5 SWOT Analysis
- 8.21.6 Strategic Implications (2026–2032)
- 8.22 MakingCosmetics(US)
- 8.22.1 Company Overview
- 8.22.2 Key Products & Segments
- 8.22.3 Financial Performance (2023–2025)
- 8.22.4 Business Strategy
- 8.22.5 SWOT Analysis
- 8.22.6 Strategic Implications (2026–2032)
- 8.23 BioSynth(CH)
- 8.23.1 Company Overview
- 8.23.2 Key Products & Segments
- 8.23.3 Financial Performance (2023–2025)
- 8.23.4 Business Strategy
- 8.23.5 SWOT Analysis
- 8.23.6 Strategic Implications (2026–2032)
- 8.24 Alidans(ES)
- 8.24.1 Company Overview
- 8.24.2 Key Products & Segments
- 8.24.3 Financial Performance (2023–2025)
- 8.24.4 Business Strategy
- 8.24.5 SWOT Analysis
- 8.24.6 Strategic Implications (2026–2032)
- 8.25 BioMolenez(FR)
- 8.25.1 Company Overview
- 8.25.2 Key Products & Segments
- 8.25.3 Financial Performance (2023–2025)
- 8.25.4 Business Strategy
- 8.25.5 SWOT Analysis
- 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Enteromorpha Compressa Extract market?
What is the forecast CAGR for the Enteromorpha Compressa Extract market?
What is Enteromorpha Compressa Extract?
How is the Enteromorpha Compressa Extract market segmented by type?
What are the key applications of Enteromorpha Compressa Extract?
Which companies are profiled in the Enteromorpha Compressa Extract market report?
What geographies does the Enteromorpha Compressa Extract market analysis include?
What are the key demand drivers for Enteromorpha Compressa Extract?
What are the main risks and barriers in the Enteromorpha Compressa Extract market?
Who should buy the Enteromorpha Compressa Extract market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Enteromorpha Compressa Extract Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials